Valmacca, Italy

Matilde Guala

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Fondazione Per L'istituto Oncologico Di Ricerca (Ior). Active years: 2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Matilde Guala. Retrieved from https://idiyas.com/inventor/matilde-guala-noednqbu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Matilde Guala: Innovator in Anti-Tumor Compounds

Introduction

Matilde Guala is a prominent inventor based in Valmacca, Italy. She has made significant contributions to the field of oncology through her innovative research and development of anti-tumor compounds. Her work focuses on creating new agents that can effectively combat various types of tumors.

Latest Patents

Matilde Guala holds a patent for her groundbreaking work titled "Compounds with Enhanced Anti-Tumor Effects." This patent describes compounds of formula (I), where the group —R may represent —O or —H. These compounds are recognized as new anti-proliferative agents that exhibit remarkable anti-tumor effects in vivo, particularly demonstrating a wide spectrum of activities against lymphomas of different origins. She has 1 patent to her name.

Career Highlights

Guala is affiliated with the Fondazione per l'Istituto Oncologico di Ricerca (IOR), where she continues her research in oncology. Her dedication to developing effective treatments for cancer has positioned her as a key figure in the field.

Collaborations

Throughout her career, Matilde has collaborated with esteemed colleagues, including Eugenio Gaudio and Francesco Bertoni. These partnerships have enhanced her research efforts and contributed to the advancement of cancer treatment methodologies.

Conclusion

Matilde Guala's innovative work in developing anti-tumor compounds showcases her commitment to improving cancer therapies. Her contributions to the field of oncology are invaluable and continue to inspire future research.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…